199 related articles for article (PubMed ID: 23652066)
21. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
[TBL] [Abstract][Full Text] [Related]
22. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.
Radulescu A; Zorko NA; Yu X; Besner GE
Pediatr Res; 2009 Apr; 65(4):437-42. PubMed ID: 19127210
[TBL] [Abstract][Full Text] [Related]
23. Dimethyloxalylglycine preserves the intestinal microvasculature and protects against intestinal injury in a neonatal mouse NEC model: role of VEGF signaling.
Bowker RM; Yan X; Managlia E; Liu SXL; Marek C; Tan XD; De Plaen IG
Pediatr Res; 2018 Feb; 83(2):545-553. PubMed ID: 29068435
[TBL] [Abstract][Full Text] [Related]
24. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
Feng J; Besner GE
J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
[TBL] [Abstract][Full Text] [Related]
25. Can we cut the incidence of necrotizing enterocolitis in half--today?
Christensen RD; Gordon PV; Besner GE
Fetal Pediatr Pathol; 2010; 29(4):185-98. PubMed ID: 20594142
[TBL] [Abstract][Full Text] [Related]
26. Nicotinamide riboside relieves the severity of experimental necrotizing enterocolitis by regulating endothelial function via eNOS deacetylation.
Zhang X; Tian B; Deng Q; Cao J; Ding X; Liu Q; Zhang Y; Ye C; Deng C; Qiu L; Guo C
Free Radic Biol Med; 2022 May; 184():218-229. PubMed ID: 35430341
[TBL] [Abstract][Full Text] [Related]
27. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
28. Remote ischemic conditioning counteracts the intestinal damage of necrotizing enterocolitis by improving intestinal microcirculation.
Koike Y; Li B; Ganji N; Zhu H; Miyake H; Chen Y; Lee C; Janssen Lok M; Zozaya C; Lau E; Lee D; Chusilp S; Zhang Z; Yamoto M; Wu RY; Inoue M; Uchida K; Kusunoki M; Delgado-Olguin P; Mertens L; Daneman A; Eaton S; Sherman PM; Pierro A
Nat Commun; 2020 Oct; 11(1):4950. PubMed ID: 33009377
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
Halpern MD; Holubec H; Clark JA; Saunders TA; Williams CS; Dvorak K; Dvorak B
Biol Neonate; 2006; 89(4):227-35. PubMed ID: 16319449
[TBL] [Abstract][Full Text] [Related]
30. The role of ischemia in necrotizing enterocolitis.
Chen Y; Chang KT; Lian DW; Lu H; Roy S; Laksmi NK; Low Y; Krishnaswamy G; Pierro A; Ong CC
J Pediatr Surg; 2016 Aug; 51(8):1255-61. PubMed ID: 26850908
[TBL] [Abstract][Full Text] [Related]
31. Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis.
Chen CL; Yu X; James IO; Zhang HY; Yang J; Radulescu A; Zhou Y; Besner GE
Lab Invest; 2012 Mar; 92(3):331-44. PubMed ID: 22157721
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis and prevention of necrotizing enterocolitis: a hypothesis based on personal observation and a review of the literature.
Kosloske AM
Pediatrics; 1984 Dec; 74(6):1086-92. PubMed ID: 6390330
[TBL] [Abstract][Full Text] [Related]
33. Effects of nitric oxide synthase inhibition on intestinal damage in rats with experimental necrotizing enterocolitis.
Ciftçi I; Dilsiz A; Aktan TM; Gürbilek M; Duman S
Eur J Pediatr Surg; 2004 Dec; 14(6):398-403. PubMed ID: 15630641
[TBL] [Abstract][Full Text] [Related]
34. Heparin-binding EGF-like growth factor is a potent dilator of terminal mesenteric arterioles.
Zhou Y; Brigstock D; Besner GE
Microvasc Res; 2009 Jun; 78(1):78-85. PubMed ID: 19389413
[TBL] [Abstract][Full Text] [Related]
35. Enteral resveratrol supplementation attenuates intestinal epithelial inducible nitric oxide synthase activity and mucosal damage in experimental necrotizing enterocolitis.
Ergün O; Ergün G; Oktem G; Selvi N; Doğan H; Tunçyürek M; Saydam G; Erdener A
J Pediatr Surg; 2007 Oct; 42(10):1687-94. PubMed ID: 17923197
[TBL] [Abstract][Full Text] [Related]
36. High-Mobility Group Box-1 Is Critical in the Pathogenesis of Mouse Experimental Necrotizing Enterocolitis.
Ye C; Zhang Y; Ding X; Guo C
J Interferon Cytokine Res; 2021 Sep; 41(9):319-328. PubMed ID: 34543127
[TBL] [Abstract][Full Text] [Related]
37. Ischemia-reperfusion and neonatal intestinal injury.
Young CM; Kingma SD; Neu J
J Pediatr; 2011 Feb; 158(2 Suppl):e25-8. PubMed ID: 21238702
[TBL] [Abstract][Full Text] [Related]
38. The plasma activities of lysosomal enzymes in infants with necrotizing enterocolitis: new promising class of biomarkers?
Benkoe TM; Mechtler TP; Pones M; Prusa AR; Klebermass-Schrehof K; Rebhandl W; Kasper DC
Clin Chim Acta; 2015 Jan; 438():279-83. PubMed ID: 25204835
[TBL] [Abstract][Full Text] [Related]
39. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts.
Hsueh W; Caplan MS; Qu XW; Tan XD; De Plaen IG; Gonzalez-Crussi F
Pediatr Dev Pathol; 2003; 6(1):6-23. PubMed ID: 12424605
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant effects of N-acetylcysteine in a neonatal rat model of necrotizing enterocolitis.
Ozdemir R; Yurttutan S; Sarı FN; Uysal B; Unverdi HG; Canpolat FE; Erdeve O; Dilmen U
J Pediatr Surg; 2012 Sep; 47(9):1652-7. PubMed ID: 22974601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
